Prevention of ischaemic events in patients with history of symptomatic ischaemic disease [especially in patients who cannot tolerate aspirin].
Mode of action
Brands containing this Ingredient
Drug Index 2.0 is hereOur new update features a more powerful search feature and easier login.
issues? Contact us
today. Contact Us
Mode of Action
Decreases platelet aggregation
Avoid few days after recent myocar- dial infarction and 7 days after ischaemic stroke, renal impairment, hepatic impairment, pregnancy, unstable angina, and patients with increased bleeding e.g. surgery.
Breast-feeding; active bleeding.
Minimal at therapeutic doses. Dizziness, abdominal distress, headache and rashes, duodenal ulceration, constipation.